Yuhan…said on the 7th it signed a strategic partnership agreement with Novartis Korea for domestic distribution, sales, and promotion of the oral multiple sclerosis treatment &#39;Rhapsido (ingredient name remibrutinib)&#39;

Rhapsido (remibrutinib) - Novartis

Sep 7, 2026